期刊文献+

前列腺癌早期诊断的分子标志物研究进展 被引量:2

原文传递
导出
摘要 前列腺癌(PCa)是男性常见恶性肿瘤。近年来在我国发病率呈上升趋势。目前前列腺癌的最常用且简便的标志物是前列腺特异性抗原(PSA)。随着对PSA的认识深入,人们发现其用于PCa早期诊断的敏感性和特异性并不理想,迫切需要寻找新的前列腺癌早期诊断的分子标志物。
作者 王志贤 马玲
出处 《中国实用医刊》 2013年第16期76-78,共3页 Chinese Journal of Practical Medicine
  • 相关文献

参考文献22

  • 1Kohli M, Tindall DJ. New developments in the medical management of prostate cancer[J]. Mayo Clin Proc ,2010,85 ( 1 ) :77-86.
  • 2顾平,盛世乐,黄钢.PSA及其它肿瘤标志物在前列腺癌中的应用[J].放射免疫学杂志,2006,19(6):507-512. 被引量:6
  • 3陈平,刘健,姚艺雄,蔡健梅,梁梅芳.t—PSA与c—PSA对前列腺癌和良性前列腺增生的鉴别诊断意义[J].国际医药卫生导报,2010,16(5):574-576. 被引量:4
  • 4Roddan AW,Duffy MJ, Hamdy FC,et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10ng/ml: systematic review and meta-analysis[ J]. Eur Uro1,2005,48 ( 3 ) : 386-399.
  • 5Thompson M, Lapointe J, Choi YL, et al. Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle [ J ]. Prostate,2008,68 ( 11 ) : 1248-1256.
  • 6Jennbacken K,Vallbo C, Wang W , et al. Expression of vascular endothelial growth factor ( VEGF-C ) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis[J]. The Prostate,2005,65 (2) : 110-116.
  • 7丁国芳,李继承,徐银峰,孙瑜,陶莉.中国人前列腺癌VEGF-C mRNA、VEGFR-3和CD31表达与肿瘤转移的关系[J].实验生物学报,2005,38(3):257-264. 被引量:7
  • 8Sung MT, Jiang Z, Montioni R,et al. Alpha-methylacyl-CoA racemase (P504s)/34 beta E12/p63 triple cocktail stain in prostate ade- nocarcinoma after hormonal therapy [ J ]. Hum Pathol, 2007,38 ( 2 ) : 332-341.
  • 9Luo J, Zha S, Goge WR, et al. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer [ J ]. Cancer Res, 2002,62 ( 8 ) :2200-2226.
  • 10Jiang Z, Fanger GR, Woda BA, et al. Expression of alpha methylacyl CoA racemase (P504s) in various malignant neoplasmas and normal tissues : a study of 761 case[J]. Hum Pathol, 2003,34 (8) :792-796.

二级参考文献118

  • 1温星桥,刘勇,黄文涛,周祥福,蔡育彬,高新.生育酚结合蛋白在前列腺癌组织的表达及意义[J].中华实验外科杂志,2006,23(10):1242-1244. 被引量:7
  • 2National Comprehensive Cancer Network. Clinical practice guidelines in ontology: prostate cancer early detection [M]. Version, 2004: 20.
  • 3D atta P, D asgupta A. Evaluation of an autom ated chemiluminescent immunoassay for complexed PSA on the Bayer ACS: 180 system[J].J Clin Lab Anal ,2003, 17 (5):174-178.
  • 4[1]Haese AC, Noldus J. Human Glandular Kallikrein2:A Potential Serum for Predicting the Organ Confined Versus Non-organ Confined Growth of Prostate Cancer[J]. Urol,2000,163:1491~1497.
  • 5[2]Becker F. Human Glandular Kallikrein2:a Tool to Improve Discrimination of Poorly Differentiated and Non-organ-confined Prostate Cancer Compared with Prostate Specific Antigen[J]. Urology,2000,55(4):481~485.
  • 6[3]蒋成淦.酶免疫测定法[M].北京:人民卫生出版社,1985.178.
  • 7[5]陶义训.免疫学和免疫学检验(第2版)[M].北京:人民卫生出版社,2000.150~152.
  • 8[7]Kwiatkowski MK, Becker F. Inprostatism Patients the Ratio of Human Glandular Kallikrein to Free PSA Improves the Discrimination between Prostate Cancer and Benign Prostatic Hyperplasia within the Diagnostic "Grey Zone" of Total PSA 4~10 ng/L[J]. Urology,1998,51:360~365.
  • 9[8]Finlay JA, Eveans CL, Day JR, et al. Development of Monoclonal Antibodies Specific for Human Glandular Kallikrein2[J]. Urology,1998,51:159~178.
  • 10[9]Nam RK, Diancondis EP. Serum Human Glandular Kallikrein2 Prostate Levels Predict the Presense of Prostate Cancer among Men with Elevated Prostate Specific Antigen(PSA)[J]. Clin Oncol,2000,18:1036~1042.

共引文献30

同被引文献24

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部